In this retrospective cohort of Malaysian patients with type 2 diabetes mellitus (T2DM) and chronic kidney disease (CKD), initiation of SGLT2 inhibitor was associated with a modest early decline of estimated glomerular filtration rate (eGFR) that stabilized over 12 months. Glycemic control improved, and changes in eGFR were not linked to HbA1c.

Acute kidney injury requiring dialysis (AKI-D) remains a significant challenge following hospital discharge, with up to one-third of patients continuing dialysis in outpatient settings. While some may recover kidney function, others progress to end-stage renal disease (ESRD).

In an interview with Professor Tan, Guang-Ming emphasized the value of adopting a localized CKM health framework—one that prioritizes early detection, fosters multidisciplinary collaboration, and drives systemic reforms to enhance patient outcomes and transforms the healthcare landscape.

Advancing "green nephrology" through eco-friendly technologies and patient-led initiatives can reduce the environmental footprint of kidney care while improving patient independence and QoL.